State Board of Administration of Florida Retirement System’s Seres Therapeutics MCRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,450
Closed -$164K 2304
2024
Q1
$164K Sell
1,450
-8
-0.5% -$173 ﹤0.01% 1975
2023
Q4
$40.8K Hold
1,458
﹤0.01% 2357
2023
Q3
$69.4K Buy
1,458
+8
+0.6% +$611 ﹤0.01% 2291
2023
Q2
$139K Hold
1,450
﹤0.01% 2203
2023
Q1
$164K Hold
1,450
﹤0.01% 2055
2022
Q4
$162K Hold
1,450
﹤0.01% 2110
2022
Q3
$186K Hold
1,450
﹤0.01% 2085
2022
Q2
$99K Hold
1,450
﹤0.01% 2254
2022
Q1
$206K Hold
1,450
﹤0.01% 2165
2021
Q4
$242K Hold
1,450
﹤0.01% 2148
2021
Q3
$202K Hold
1,450
﹤0.01% 2259
2021
Q2
$692K Buy
1,450
+266
+22% +$112K ﹤0.01% 1684
2021
Q1
$487K Sell
1,184
-401
-25% -$185K ﹤0.01% 1817
2020
Q4
$777K Sell
1,585
-38
-2% -$22.3K ﹤0.01% 1537
2020
Q3
$919K Hold
1,623
﹤0.01% 1328
2020
Q2
$154K Buy
+1,623
New +$142K ﹤0.01% 2141

Other funds holding MCRB

State Board of Administration of Florida Retirement System's MCRB Position: Q2 2024 in Review

State Board of Administration of Florida Retirement System sold out of Seres Therapeutics (MCRB) in Q2 2024, closing a stake of 1,450 shares — an estimated $164K sold.

State Board of Administration of Florida Retirement System first reported a position in MCRB in Q2 2020 and held it in 16 quarters. The position peaked at $919K in Q3 2020. 93 funds tracked by Wall St. Rank hold MCRB as of Q2 2024.

  • State Board of Administration of Florida Retirement System reported no remaining Seres Therapeutics position as of Q2 2024 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 1,450 Seres Therapeutics shares in Q2 2024, an estimated $164K.
  • State Board of Administration of Florida Retirement System first reported a position in Seres Therapeutics in Q2 2020 and held it in 16 quarters.
  • State Board of Administration of Florida Retirement System's Seres Therapeutics position peaked at $919K in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2024, filed 8 Aug 2024.